ClinicalTrials.Veeva

Menu

Serial Assessment of Body Fat Accrual in Very Preterm Infants

The University of Alabama at Birmingham logo

The University of Alabama at Birmingham

Status

Active, not recruiting

Conditions

Infant,Premature
Adiposity
Body Weight

Treatments

Diagnostic Test: Assessment of infant body composition

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT03575897
300001753
2U54MD000502 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

Despite evidence that both rapid weight gain and excessive body fat accrual are associated with overweight and obesity, usual neonatal care of preterm infants does not include assessment of body fat accrual. The study hypothesis is that identification of early changes in infant body composition (i.e. amount of fat mass and fat-free mass) reduces % body fat at 3 months of age.

Full description

Infants in the intervention group will have the information about infant body composition known to the clinicians caring for them (including reference data). Infants in the control group will also undergo serial measurements of infant body composition, but this information will not be available to the clinicians.

If parent agrees, stool "dirty" diapers will be collected 2 times (at the time of hospital discharge and at 3 months of corrected age).

Enrollment

50 patients

Sex

All

Ages

1 to 14 days old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Gestational age between 28 and 32 weeks of gestation

Exclusion criteria

  • Gastrointestinal or neurologic malformations
  • Terminal illness requiring limited or withheld support

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

50 participants in 2 patient groups

Intervention Group
Experimental group
Description:
Infants randomly assigned to the intervention group will undergo serial measurements of infant body composition during their hospitalization. This information about infant body composition will be known to the clinicians caring for them (including reference data).
Treatment:
Diagnostic Test: Assessment of infant body composition
Control Group
Active Comparator group
Description:
Infants randomly assigned to the control group will also undergo serial measurements of infant body composition during their hospitalization, but this information will not be available to the clinicians caring for them.
Treatment:
Diagnostic Test: Assessment of infant body composition

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems